Tremfya 100 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FCX9S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,306
Award facts
- Contract value 100% obligated
- $24,306.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $24.3K, was awarded on January 6, 2026, to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 MG/ML in pen form. The award is a firm fixed-price contract with no set-aside designation, competitively awarded through the Defense Logistics Agency (DLA). Performance will be completed at the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 7, 2026. This order is issued under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the military healthcare system.
AmerisourceBergen operates as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The company maintains extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. TREMFYA is a specialty pharmaceutical product used in dermatological treatment, reflecting the company's role in supplying both routine and specialized medications essential to military treatment facilities and federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FCX9S?
SPE2DR26FCX9S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FCX9S worth?
The government has obligated $24,306 on SPE2DR26FCX9S.
Is contract SPE2DR26FCX9S an order under another contract?
Yes. SPE2DR26FCX9S is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCX9S competed?
The extent of competition for SPE2DR26FCX9S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award